Sinopharm Vaccine Falls Short on Antibodies in Budapest Study

[Yongpeng Sun-Tastaufen]

Sinopharm Vaccine Falls Short on Antibodies in Budapest Study

The Chinese-made Sinopharm vaccine has failed to produce sufficient antibodies in a quarter of elderly people who were voluntarily tested in Budapest, according to a study by the opposition-led Budapest City Hall.

www.bloomberg.com

The Chinese-made Sinopharm vaccine has failed to produce sufficient antibodies in a quarter of elderly people who were voluntarily tested in Budapest, according to a study by the opposition-led Budapest City Hall.

The results were published just as Hungarian Prime Minister Viktor Orban’s government, which has faced opposition criticism for having widely adminsitered Sinopharm shots to older people, started offering third shots this week for anyone who requests them.




Hungary, which has had the highest level of Covid-19 deaths per capita after Peru, was the only European Union country to have deployed the Sinopharm vaccine to combat Covid-19.


The non-representative study tested 13,524 people who were at least 60 years old. More than half had been inoculated with Sinopharm.

The results showed that 25.9% of those people didn’t have the minimum antibody level of 50 AU per milliliter, compared with 3.2% for those who received Russia’s Sputnik V, 1.6% for Pfizer-BioNtech and 1.1% for Moderna.




Sinopharm’s ability to generate antibodies got progressively worse with age, with vaccinated people who didn’t have the minimum antibody level rising to 34.5% among those aged 80 and over, the results showed.

Orban’s government cited the initial slow pace of procuring Pfizer’s and Moderna’s vaccines for buying the shots from China and Russia. The country has also used the AstraZeneca and Janssen vaccines.

 

[Ali_Baba]

The problem is that Pakistan is paying good money(via loans aswell) for vaccines that are not as effective as AstraZeneca/Pfizer/Moderna.

Sputnik is meant to be quite effective.

How much is China charging for a doe of Sinopharm ?

 

[Yongpeng Sun-Tastaufen]

The problem is that Pakistan is paying good money(via loans aswell) for vaccines that are not as effective as AstraZeneca/Pfizer/Moderna.

Sputnik is meant to be quite effective.

How much is China charging for a doe of Sinopharm ?

Comparing Sinopharm with Pfizer/Moderna is like comparing crossbow with longbow. Both have their advantages and disadvantages. Whereas Pfizer/Moderna arguably has a bit better efficacy for young people, they are hard to store and require very low temperatures and have short shelf life, problems Sinopharm does not have.

 

[nang2]

Comparing Sinopharm with Pfizer/Moderna is like comparing crossbow with longbow. Both have their advantages and disadvantages. Whereas Pfizer/Moderna arguably has a bit better efficacy for young people, they are hard to store and require very low temperatures and have short shelf life, problems Sinopharm does not have.

Why do you compare medicinal advantage of Pfizer/Moderna with logisitic advantage with Sinopharm? It is not like comparing crossbow with longbow. It is like comparing apple with orange.